ZURICH, August 2014: Biotechgate announces the launch of a new database which provides information on investors seeking investment opportunities within the life science industry. With the help of the database, capital raising companies can identify specific investors and retrieve the contact details of the responsible persons.
The new Biotechgate Investor Database is a life science-specific platform available to scientists and entrepreneurs raising capital. The data is collected and curated by a dedicated investor research team. The completion of the investor profiles starts with a web-research and validation of current information. This is enhanced by continuous conversations with investors to identify their current needs and active mandates. This unique approach enables fundraising executives to use the Biotechgate Investor Database to match up with investors that are a fit for their particular financing stage, disease area or technology, resulting in a more effective and efficient fundraising process.
The Investor Database is an online application and comes with a user-friendly interface that allows easy filtering to identify specific investors. The focus is on alternative investors like Family Offices/Private Wealth Funds, Corporate Investors, Angel Groups and Endowments/Foundations. The database wants to provide subscribers access to difficult to find investors as an alternative to Venture Capital money. Everything including contact information can be downloaded into Excel for effective targeting of potential investors. The content in the database is maintained by Biotechgate’s collaboration partner Life Science Nation (LSN), Boston, USA.
“We are delighted to launch the Biotechgate Investor Database with thousands of updated investor profiles. This new feature closes an important gap within Biotechgate as fundraising is a key task of any biotech and life sciences executive”, says Jost Renggli, COO of Biotechgate / Venture Valuation.
For further information, please contact:
Alan Jones, Senior Business Development Executive
firstname.lastname@example.org | +41 (44) 500 38 48
Jost Renggli, COO & Partner
email@example.com | +41 (43) 321 86 60
by Venture Valuation AG | Kasernenstrasse 11 | 8004 Zurich | Switzerland
T +41 (43) 321 86 60 | F +41 (43) 321 86 61 | firstname.lastname@example.org
Click here to download the press release : Biotechgate launches Investor Database, Zurich, August 2014, 2 pages, 86kb